Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126287742 | 12628774 | 2 | F | 20160801 | 20160808 | 20160810 | EXP | IT-ACCORD-042852 | ACCORD | FOIS C, RASSU AL, SECHI E, ADDIS A, PIREDDA R, DEMURTAS R, ET AL. UNPREDICTABLE SEIZUREWORSENING INDUCED BY LEVETIRACETAM MONOTHERAPY IN A PATIENT WITH FOCAL CORTICAL DYSPLASIA TYPE II. EUR-J-NEUROL 2016;23 (SUPPL. S2)172-173 ABSTR. P11131 | 0.00 | Y | 0.00000 | 20160810 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126287742 | 12628774 | 1 | PS | LEVETIRACETAM. | LEVETIRACETAM | 1 | U | 90843 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126287742 | 12628774 | 1 | Epilepsy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126287742 | 12628774 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126287742 | 12628774 | Condition aggravated | |
| 126287742 | 12628774 | Incorrect dose administered | |
| 126287742 | 12628774 | Paradoxical drug reaction | |
| 126287742 | 12628774 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |